Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15449526 | 0.93 | MAPK1 (0.42) | CYP2A6MAPTLDHAALOX15MAPK1 | |
| SCHEMBL14477632 | 0.86 | MEN1 (0.33) | MEN1KMT2ACA2CA1CA9 | |
| SCHEMBL390464 | 0.78 | CYP2A6 (0.47) | CYP2A6MAPTLDHAALOX15MAPK1 | |
| SCHEMBL12201784 | 0.77 | CYP2A6 (0.48) | CYP2A6MAPTMAPK1MEN1LMNA | |
| SCHEMBL79980 | 0.76 | ESR2 (0.52) | MAPTALOX15MEN1LMNARAB9A | |
| SCHEMBL121643 | 0.74 | NFE2L2 (0.37) | LMNACA2CA1CA9MAOA | |
| SCHEMBL626870 | 0.74 | LMNA (0.42) | CYP2A6MAPTALOX15MEN1LMNA | |
| SCHEMBL15836111 | 0.74 | CYP3A4 (0.32) | TSHR | |
| SCHEMBL5148477 | 0.74 | ALDH1A1 (0.50) | MAPTALOX15MAPK1MEN1RAB9A | |
| SCHEMBL819814 | 0.74 | CA1 (0.58) | MAPTMAPK1RAB9ANPSR1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11825740-B2 | Amine compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-21 | — | — | US | disclosed |
| US-11805697-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-31 | — | — | US | disclosed |
| WO-2023125716-A1 | CLASS OF QUINOLINE COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 中国科学院上海药物研究所 | 2023-07-06 | — | — | WO | disclosed |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | RQX PHARMACEUTICALS INC (US) | 2023-05-04 | — | — | US | disclosed |
| CN-114773136-A | Method for synthesizing arylamine | 陕西师范大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20180212158-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2018-07-26 | — | — | US | disclosed |
| US-20180064692-A1 | Anti-Fibrotic Pyridinones | GENENTECH, INC. | 2018-03-08 | — | — | US | disclosed |
| US-20170338421-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-11-23 | — | — | US | disclosed |
| US-20170309838-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-26 | — | — | US | disclosed |
| US-20170253614-A1 | HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS | CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) | 2017-09-07 | — | — | US | disclosed |
| US-20130072449-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-20130037782-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-14 | — | — | US | disclosed |
| US-20130032787-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-07 | — | — | US | disclosed |
| US-20130020562-A1 | POLYMER COMPOUND, NET-LIKE POLYMER COMPOUND PRODUCED BY CROSSLINKING THE POLYMER COMPOUND, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC EL DISPLAY, AND ORGANIC EL LIGHTING | MITSUBISHI CHEMICAL CORPORATION | 2013-01-24 | — | — | US | disclosed |
| US-20120122864-A1 | INHIBITORS OF HCV NS5A | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20110284827-A1 | INDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
| US-20110108814-A1 | POLYMER COMPOUND, NET-LIKE POLYMER COMPOUND PRODUCED BY CROSSLINKING THE POLYMER COMPOUND, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC EL DISPLAY, AND ORGANIC EL LIGHTING | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-12 | — | — | US | disclosed |
| US-20110054175-A1 | SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2011-03-03 | — | — | US | disclosed |
| US-20110054228-A1 | BLUE ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2011-03-03 | — | — | US | disclosed |
| US-20110042661-A1 | CONJUGATED POLYMER, INSOLUBILIZED POLYMER, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, POLYMER PRODUCTION PROCESS, ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC EL DISPLAY AND ORGANIC EL LIGHTING | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170338421-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OR10J3, TRMT1L, OSGEP | CYP2A6 4622/4885MAPT 75/4885LDHA 393/4885 |
| US-20170309838-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OR10J3, TRMT1L, OSGEP | CYP2A6 4622/4885MAPT 75/4885LDHA 393/4885 |
| US-20180064692-A1 | Anti-Fibrotic Pyridinones | MMP1, COL1A1, COL2A1 | CYP2A6 3111/4885MAPT 4377/4885LDHA 2646/4885 |
| US-20130072449-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR5 | CYP2A6 3293/4885MAPT 4564/4885LDHA 2038/4885 |
| US-20170253614-A1 | HEPATITIS C VIRUS INHIBITORS AND USES THEREOF IN PREPARATION OF DRUGS | HAVCR2, HCCS, LIPC | CYP2A6 555/4885MAPT 3166/4885LDHA 1456/4885 |
| US-20110284827-A1 | INDENOFLUORENEDIONE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | HSD17B11, HSD17B2, HSD17B1 | CYP2A6 1320/4885MAPT 1503/4885LDHA 1372/4885 |
| US-20180212158-A1 | ORGANIC LIGHT-EMITTING DIODE MATERIALS | MSN, DDT, NECTIN4 | CYP2A6 2024/4885MAPT 609/4885LDHA 95/4885 |
| US-20120122864-A1 | INHIBITORS OF HCV NS5A | HAVCR2, MAVS, EIF2AK2 | CYP2A6 2995/4885MAPT 3250/4885LDHA 4110/4885 |
| US-11805697-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SLC18A2, SLC18A1, MAOA | CYP2A6 758/4885MAPT 683/4885LDHA 310/4885 |
| US-20130032787-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | PER2, CRY2, TELO2 | CYP2A6 742/4885MAPT 1824/4885LDHA 2028/4885 |
| US-20130037782-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | DRD1, OPRD1, OXER1 | CYP2A6 409/4885MAPT 1135/4885LDHA 1091/4885 |
| US-20110054175-A1 | SYSTEM FOR FLUORINATING ORGANIC COMPOUNDS | PFAS, ODC1, AOC1 | CYP2A6 1838/4885MAPT 2637/4885LDHA 4026/4885 |
| US-20230133667-A1 | MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS | MRPL21, PEPD, CTSC | CYP2A6 3516/4885MAPT 4006/4885LDHA 2309/4885 |
| US-20110054228-A1 | BLUE ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND DISPLAY DEVICE USING THE SAME | ORMDL3, OCIAD2, OCIAD1 | CYP2A6 1788/4885MAPT 888/4885LDHA 627/4885 |
| US-11825740-B2 | Amine compound and organic light-emitting device including the same | AOC2, AOC1, AOC3 | CYP2A6 2184/4885MAPT 446/4885LDHA 447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.